Daniel Brixner
4 Papers
Daniel Brixner is an academic researcher. The author has contributed to research in topics: Critical limb ischemia & Prospective cohort study. The author has an hindex of 4, co-authored 4 publications.
Chat about Author
Papers
In-hospital outcomes in patients with critical limb ischemia and end-stage renal disease after revascularization
Alexander Meyer,Werner Lang,Matthias Borowski,Giovanni Torsello,Theodosios Bisdas,Thomas Schmitz-Rixen,Asimakis Gkremoutis,Markus Steinbauer,Thomas Betz,Hans-Henning Eckstein,Alexander Zimmermann,Hubert Schelzig,Alexander Oberhuber,Hans-Joachim Florek,Björn May,Martin Storck,B.T. Weis-Müller,Christian Reinhold,Dittmar Böckler,Arend Billing,Daniel Brixner,Thomas Hupp,Joachim Gerß,Sebastian Debus,Mathias Spohn,Holger Reinecke,Christian Schlensack,Konstantinos P. Donas,Konstantinos Stavroulakis,Wojciech Klonek,Heiner Wenk,Matthias Trede,Ralf-Gerhard Ritter,Karl-Ludwig Schulte,Tobias Keck,K. Balzer,Bernhard Mühling,Farzin Adili,Reinhardt Grundmann,Thomas Zeller +39 more
TL;DR: Analysis of in-hospital outcomes in patients treated for critical limb ischemia and end-stage renal disease compared to CLI patients with normal renal function suggests that endovascular therapy is generally considered as the most favorable treatment option in this patient subgroup.
50
Outcomes of dialysis patients with critical limb ischemia after revascularization compared with patients with normal renal function
Alexander Meyer,Cornelia Fiessler,Konstantinos Stavroulakis,Giovanni Torsello,Theodosios Bisdas,Werner Lang,Farzin Adili,K. Balzer,Arend Billing,Dittmar Böckler,Daniel Brixner,Sebastian Debus,Konstantinos P. Donas,Hans-Henning Eckstein,Hans-Joachim Florek,Asimakis Gkremoutis,Reinhardt Grundmann,Thomas Hupp,Tobias Keck,Joachim Gerß,Klonek Wojciech,Björn May,Bernhard Mühling,Alexander Oberhuber,Holger Reinecke,Christian Reinhold,Ralf-Gerhard Ritter,Hubert Schelzig,Christian Schlensack,Thomas Schmitz-Rixen,Karl-Ludwig Schulte,Mathias Spohn,Markus Steinbauer,Martin Storck,Matthias Trede,Christian Uhl,B.T. Weis-Müller,Heiner Wenk,Thomas Zeller,Alexander Zimmermann +39 more
TL;DR: Two‐year AFS, overall survival, and freedom from major amputation were decreased in ESRD patients compared with non‐ESRD patients with critical limb ischemia; surgical revascularization and EVT may be used as complementary options.
42
Current practice of first-line treatment strategies in patients with critical limb ischemia.
Theodosios Bisdas,Matthias Borowski,Giovanni Torsello,Farzin Adili,K. Balzer,Thomas Betz,Arend Billing,Dittmar Böckler,Daniel Brixner,Sebastian Debus,Konstantinos P. Donas,Hans-Henning Eckstein,Hans-Joachim Florek,Asimakis Gkremoutis,Reinhardt Grundmann,Thomas Hupp,Tobias Keck,Joachim Gerß,Wojciech Klonek,Werner Lang,Ute Ludwig,Björn May,Alexander Meyer,Bernhard Mühling,Alexander Oberhuber,Holger Reinecke,Christian Reinhold,Ralf-Gerhard Ritter,Hubert Schelzig,Christian Schlensack,Thomas Schmitz-Rixen,Karl-Ludwig Schulte,Matthias Spohn,Konstantinos Stavroulakis,Markus Steinbauer,Martin Storck,Matthias Trede,B.T. Weis-Müller,Heiner Wenk,Thomas Zeller,Alexander Zimmermann +40 more
TL;DR: The CRITISCH registry revealed ER as the most common first-line approach in CLI patients, and coronary artery disease and PMI and previous myocardial infarction <6 months were independent risk factors for the composite end point.
Association between statin therapy and amputation-free survival in patients with critical limb ischemia in the CRITISCH registry
Konstantinos Stavroulakis,Matthias Borowski,Giovanni Torsello,Theodosios Bisdas,Farzin Adili,K. Balzer,Arend Billing,Dittmar Böckler,Daniel Brixner,Sebastian Debus,Hans-Henning Eckstein,Hans-Joachim Florek,Asimakis Gkremoutis,Reinhardt Grundmann,Thomas Hupp,Tobias Keck,Joachim Gerß,Wojciech Klonek,Werner Lang,Björn May,Alexander Meyer,Bernhard Mühling,Alexander Oberhuber,Holger Reinecke,Christian Reinhold,Ralf-Gerhard Ritter,Hubert Schelzig,Christian Schlensack,Thomas Schmitz-Rixen,Karl-Ludwig Schulte,Matthias Spohn,Markus Steinbauer,Martin Storck,Matthias Trede,Christian Uhl,B.T. Weis-Müller,Heiner Wenk,Thomas Zeller,Sven Zhorzel,Alexander Zimmermann +39 more
TL;DR: Statin therapy in CLI patients is associated with an increased AFS and lower rates of mortality and MACCEs without improving, however, the salvage rates of the affected limb.